Русский
English
عربي
Mash Premiere for Pharmaceutical Industries
Over more than 32 years, the company has achieved significant growth, expanding its product range to include 280 products, which include 225 pharmaceutical products, 103 cosmetic products, and 25 dietary supplements.
Key Areas of Focus:
- Pharmaceutical Products: Developing and manufacturing medicines across various therapeutic areas, including virology, central nervous system, cardiovascular diseases, gastrointestinal diseases, dermatology, urology, and antibiotics.
- Cosmetic Products: Creating dermocosmetic products for skincare and haircare.
- Dietary Supplements: Developing health and nutritional products.
Global Presence:
Mash Premiere's products are available in over 20 countries, including regions in Asia, Africa, Latin America, and the CIS countries.
Manufacturing Capabilities:
The company operates two highly equipped pharmaceutical manufacturing plants that comply with World Health Organization (WHO) guidelines and Good Manufacturing Practice (GMP) standards. Additionally, the company is currently building a new plant, "Mash TECH," which will feature specialized areas for oncology drugs and sterile environments for lyophilized vials and ampoules.
Achievements:
In 2015 and 2016, Mash Premiere was recognized as the fastest-growing national pharmaceutical company in the MENA region by IMS. The company has also been acknowledged by the World Health Organization for its unique contribution to combating epidemic diseases, such as Hepatitis C, in Egypt.
Brand products
